Camlin Fine Sciences Limited

CAMLINFINE

INE052I01032

Specialty Chemicals

Delayed Bombay S.E. Other stock markets 01:39:18 2024-05-17 am EDT			5-day change	1st Jan Change
100.8 ^INR	+1.61%		-0.25%	-26.02%

Feb. 09	Transcript : Camlin Fine Sciences Limited, Q3 2024 Earnings Call, Feb 09, 2024
Feb. 09	Camlin Fine Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Camlin Fine Sciences Limited Announces Appointment of Ashish Dandekar as Chairman of the Board

June 17, 2021 at 08:20 am EDT

The board of directors of Camlin Fine Sciences Limited passed a resolution on June 17, 2021, appointment of Mr. Ashish Dandekar as Chairman of the Board with effect from June 17, 2021.

Latest news about Camlin Fine Sciences Limited

Transcript : Camlin Fine Sciences Limited, Q3 2024 Earnings Call, Feb 09, 2024	Feb. 09
Camlin Fine Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Transcript : Camlin Fine Sciences Limited, Q2 2024 Earnings Call, Nov 06, 2023	Nov. 06
Camlin Fine Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 06	CI
Camlin Fine Sciences Limited Appoints Nilesh Jadhav as Chief Operating Officer	Nov. 06	CI
Transcript : Camlin Fine Sciences Limited - Shareholder/Analyst Call	23-09-18
Camlin Fine Sciences Arm Extends Closure of Diphenol Plant in Italy	23-09-15	MT
Infinity Direct Holdings and Infinity Direct Holdings Sidecar I completed the acquisition of 9.7% stake in Camlin Fine Sciences Limited for INR 2.7 billion.	23-08-30	CI
Camlin Fine Sciences Unit Shuts Diphenol Plant in Europe	23-08-16	MT
Camlin Fine Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Univar Solutions Named Authorized Distributor for Camlin Fine Sciences' Aroma Ingredients in US, Canada	23-06-29	MT
Camlin Fine Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-22	CI
Camlin Fine Sciences Limited Announces Mr. Sarvjit Bedi Resigns as Non-Executive Director	23-04-19	CI
Infinity Direct Holdings and Infinity Direct Holdings Sidecar I made an offer to acquire 26% stake in Camlin Fine Sciences Limited for INR 7.1 billion.	23-04-16	CI
Camlin Fine Sciences Limited Announces the Resignation of Thomas Videbæk as Non-Executive Independent Director, Effective February 23, 2023	23-02-20	CI
Transcript : Camlin Fine Sciences Limited, Q3 2023 Earnings Call, Feb 14, 2023	23-02-14
Camlin Fine Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Camlin Fine Sciences Begins Commercial Production at New Unit in Gujarat, India	23-01-22	MT
Transcript : Camlin Fine Sciences Limited, Q2 2023 Earnings Call, Nov 12, 2022	22-11-12
Camlin Fine Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Transcript : Camlin Fine Sciences Limited, Q1 2023 Earnings Call, Aug 12, 2022	22-08-12
Camlin Fine Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Camlin Fine Sciences Limited Announces Change in Registered Office Address	22-08-09	CI
Transcript : Camlin Fine Sciences Limited, Q4 2022 Earnings Call, May 20, 2022	22-05-20
Camlin Fine Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-19	CI

Chart Camlin Fine Sciences Limited

Duration

Period

More charts

Camlin Fine Sciences Limited is an India-based company, which is engaged in research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The Company manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. Its products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances and health care.

Sector

Specialty Chemicals

Calendar

2024-05-19 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Camlin Fine Sciences Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

99.2 INR

Average target price

150 INR

Spread / Average Target

+51.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
CAMLIN FINE SCIENCES LIMITED	-26.02%	199M
ECOLAB INC.	+17.29%	66.43B
SIKA AG	+2.81%	49.89B
GIVAUDAN SA	+17.88%	41.88B
FUJIFILM HOLDINGS CORPORATION	+20.74%	26.48B
EMS-CHEMIE HOLDING AG	+11.82%	19.68B
CELANESE CORPORATION	+0.19%	17B
POSCO FUTURE M CO., LTD.	-21.87%	16.12B
SYMRISE AG	+0.91%	15.28B
ALBEMARLE CORPORATION	-10.58%	15.18B

Other Specialty Chemicals